<p>Estradiol promotes the progression of ER+ breast cancer through methylation-mediated RSK4 inactivation</p>

Qiuyun Li(Tumor Hospital of Guangxi Medical University), Yi Jiang(Tumor Hospital of Guangxi Medical University)
OncoTargets and Therapy
July 1, 2019
Cited by 16


Related Papers